These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3504718)

  • 1. Progression of mineral metabolism derangements in childhood chronic renal failure.
    Bianchi ML; Claris-Appiani A; Romeo L; Soldati L; Marra G; Bini P; Ortolani S
    Bone Miner; 1986 Dec; 1(6):475-83. PubMed ID: 3504718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Levels of plasma 1,25-dihydroxyvitamin D and parameters of phospho-calcium metabolism in children with non-dialyzed chronic renal failure].
    Loras B; Parchoux B; Durr F
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():755-60. PubMed ID: 6897703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.
    Christiansen C; Christensen MS; Melsen F; Rødbro P; DeLuca HF
    Clin Nephrol; 1981 Jan; 15(1):18-22. PubMed ID: 7214748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D metabolites in renal insufficiency and other vitamin D disorders of children.
    Chesney RW; Hamstra AJ; Phelps M; DeLuca HF
    Kidney Int Suppl; 1983 Nov; 15():S63-9. PubMed ID: 6584678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ratio of parathyroid hormone to 1,25-dihydroxycholecalciferol in early renal failure.
    Lucas PA; Brown RC; Woodhead JS; Coles GA
    Kidney Int Suppl; 1983 Dec; 16():S171-4. PubMed ID: 6588249
    [No Abstract]   [Full Text] [Related]  

  • 6. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
    Pistor K; Reinhardt D; Grosse-Hohmann E; Keck E
    Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disturbances in mineral metabolism after successful renal transplantation.
    Sakhaee K; Brinker K; Helderman JH; Bengfort JL; Nicar MJ; Hull AR; Pak CY
    Miner Electrolyte Metab; 1985; 11(3):167-72. PubMed ID: 3892264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of bone mineral density and bone metabolism in patients with various grades of chronic pancreatitis.
    Mann ST; Stracke H; Lange U; Klör HU; Teichmann J
    Metabolism; 2003 May; 52(5):579-85. PubMed ID: 12759887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of vitamin D metabolism and bone mineral content after intestinal bypass for obesity. A longitudinal study.
    Rickers H; Christiansen C; Balslev I; Rødbro P
    Scand J Gastroenterol; 1984 Mar; 19(2):184-9. PubMed ID: 6609420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease/bone and mineral metabolism: the imperfect storm.
    Williams ME
    Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone health in chronic kidney disease-mineral and bone disease.
    Gal-Moscovici A; Sprague SM
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):27-36. PubMed ID: 17200041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineral metabolism and mortality in patients with chronic kidney disease.
    Young EW
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):13-21. PubMed ID: 17200039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 1,25-dihydroxyvitamin-D3 on renal function, mineral balance, and growth in children with severe chronic renal failure.
    Chan JC; Kodroff MB; Landwehr DM
    Pediatrics; 1981 Oct; 68(4):559-71. PubMed ID: 6895662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of a phosphatonin in mineral homeostasis and its derangements.
    Bielesz B
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():34-42. PubMed ID: 16884396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of orthotopic liver transplantation on bone mineral content and serum vitamin D metabolites in infants and children with chronic cholestasis.
    Argao EA; Balistreri WF; Hollis BW; Ryckman FC; Heubi JE
    Hepatology; 1994 Sep; 20(3):598-603. PubMed ID: 8076918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of age on bone mineral regulating hormones.
    Epstein S; Bryce G; Hinman JW; Miller ON; Riggs BL; Hui SL; Johnston CC
    Bone; 1986; 7(6):421-5. PubMed ID: 3801234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.